National Center for Child Health and Development

Patent Applications and Registrations

Patent applications and USPTO patent grants for National Center for Child Health and Development.The latest application filed is for "pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor".

Company Profile

8.13.16

National Center for Child Health and Development - Tokyo JP
National Center for Child Health and Development - Setagaya-ku, Tokyo N/A JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Composition For Enhancing Antitumor Effect By Immune Checkpoint Inhibitor App 20200297674 - Tanaka; Tohru ; et al.	2020-09-24
Method For Preparation Of Retinal Ganglion Cells App 20200270572 - Azuma; Noriyuki ; et al.	2020-08-27
Antisense Oligonucleotide And Composition For Prevention Or Treatment Of Glycogen Storage Disease Type Ia App 20200246369A1 -	2020-08-06
Method for Primary Prevention of Allergic Disorders During Infancy Through IgE-Class-Specific Immunosuppression App 20200231705A1 -	2020-07-23
Gut Organoid And Method For Producing The Same App 20200102543 - OKAZAKI; Takuya ; et al.	2020-04-02
Method for preparation of retinal ganglion cells Grant 10,584,314 - Azuma , et al.	2020-03-10
Method Of Amplifying A Polynucleotide Of Interest App 20190360031 - Uchiyama; Toru ; et al.	2019-11-28
Method And Composition For Preventing Egg Allergy App 20180214494 - OHYA; Yukihiro ; et al.	2018-08-02
Enhancer of survival of transplanted organ Grant 9,937,138 - Rii , et al. April 10, 2	2018-04-10
Enhancer of survival of transplanted organ Grant 9,901,558 - Rii , et al. February 27, 2	2018-02-27
Organ Preservation Solution App 20170202210 - TANAKA; Tohru ; et al.	2017-07-20
Method For Preparation Of Retinal Ganglion Cells App 20170191033 - Azuma; Noriyuki ; et al.	2017-07-06
Endoscope Grant 9,565,993 - Okuda , et al. February 14, 2	2017-02-14
DNA controlling miR-140 expression, and screening method of drugs using said DNA Grant 9,557,327 - Asahara , et al. January 31, 2	2017-01-31
Novel Chimeric Gene Atf7ip-pdgfrb Of Acute Lymphoblastic Leukemia App 20160289663 - Kiyokawa; Nobutaka ; et al.	2016-10-06
Immune tolerance inducer Grant 9,399,029 - Tanaka , et al. July 26, 2	2016-07-26
Enhancer Of Survival Of Transplanted Organ App 20160206582 - RII; Ko ; et al.	2016-07-21
Enhancer Of Survival Of Transplanted Organ App 20160184250 - RII; Ko ; et al.	2016-06-30
Enhancer of survival of transplanted organ Grant 9,314,443 - Rii , et al. April 19, 2	2016-04-19
Immune Tolerance Inducer App 20150174090 - Tanaka; Tohru ; et al.	2015-06-25
Endoscope App 20150157194 - Okuda; Yoshiyuki ; et al.	2015-06-11
Dna Controlling Mir-140 Expression, And Screening Method Of Drugs Using Said Dna App 20150056630 - Asahara; Hiroshi ; et al.	2015-02-26
Frozen Cell Immobilized Product, Primary Hepatocyte Culture Tool, And Method For Producing Primary Hepatocyte Culture Tool App 20100216245 - Enosawa; Shin ; et al.	2010-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.